Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.

    Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS.

    Diabetes. 2008 Sep;57(9):2547-51.PMID: 18753673 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case - control and follow - up studies.

    Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS.

    Diabetes. 2008 Jun 5. [Epub ahead of print]PMID: 18535186 [PubMed - as supplied by publisher]Related articles

    3.

    Re: Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.

    Bakker SJ, Alkhalaf A, Tarnow L, Navis G.

    Diabetes. 2008 Dec;57(12):e16; author reply e17. No abstract available. PMID: 19033401 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans.

    McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW.

    Hum Genet. 2009 Aug;126(2):265-75. Epub 2009 Apr 17.PMID: 19373489 [PubMed - indexed for MEDLINE]Related articles

    5.

    A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.

    Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW.

    Nephrol Dial Transplant. 2007 Apr;22(4):1131-5. Epub 2007 Jan 5.PMID: 17205963 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.

    Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, Wanic K, Moczulski D, Canani L, Araki S, Makita Y, Warram JH, Krolewski AS.

    Diabetes. 2008 Sep;57(9):2519-26. Epub 2008 Jun 16.PMID: 18559660 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.

    Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Köppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ.

    Diabetes. 2005 Aug;54(8):2320-7.PMID: 16046297 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.

    Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS.

    Kidney Int. 2000 Feb;57(2):405-13.PMID: 10652017 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.

    Savage DA, Patterson CC, Deloukas P, Whittaker P, McKnight AJ, Morrison J, Boulton AJ, Demaine AG, Marshall SM, Millward BA, Thomas SM, Viberti GC, Walker JD, Sadlier D, Maxwell AP, Bain SC.

    Diabetologia. 2008 Nov;51(11):1998-2002. Epub 2008 Sep 5.PMID: 18773191 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells.

    Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, Sauerhoefer S, Janssen B, van der Woude FJ, Yard BA.

    Diabetes. 2007 Sep;56(9):2410-3. Epub 2007 Jun 29.PMID: 17601991 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.

    Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS.

    Am J Kidney Dis. 2003 Jun;41(6):1189-94.PMID: 12776270 [PubMed - indexed for MEDLINE]Related articles

    13.

    The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.

    Jorsal A, Tarnow L, Lajer M, Ek J, Hansen T, Pedersen O, Parving HH.

    Mol Genet Metab. 2008 Jul;94(3):347-51. Epub 2008 May 7.PMID: 18467141 [PubMed - indexed for MEDLINE]Related articles

    14.

    Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.

    Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, Ng DP, Placha G, Canani LH, Bochenski J, Waggott D, Merchant ML, Krolewski B, Mirea L, Wanic K, Katavetin P, Kure M, Wolkow P, Dunn JS, Smiles A, Walker WH, Boright AP, Bull SB; DCCT/EDIC Research Group, Doria A, Rogus JJ, Rich SS, Warram JH, Krolewski AS.

    Diabetes. 2009 Jun;58(6):1403-10. Epub 2009 Feb 27.PMID: 19252134 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus.

    Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC, El Nahas AM, Plater ME, Shaw J, Boulton AJ, Duff GW, Cox A.

    Diabet Med. 2001 Nov;18(11):906-14.PMID: 11703436 [PubMed - indexed for MEDLINE]Related articles

    16.

    Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes.

    Ng DP, Nurbaya S, Choo S, Koh D, Chia KS, Krolewski AS.

    Nephrol Dial Transplant. 2008 Jul;23(7):2260-4. Epub 2008 Feb 10.PMID: 18263927 [PubMed - indexed for MEDLINE]Related articles

    17.

    Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.

    Lajer M, Tarnow L, Fleckner J, Hansen BV, Edwards DG, Parving HH, Boel E.

    Diabet Med. 2004 Aug;21(8):867-73.PMID: 15270790 [PubMed - indexed for MEDLINE]Related articles

    18.

    Investigation of DNA polymorphisms in SMAD genes for genetic predisposition to diabetic nephropathy in patients with type 1 diabetes mellitus.

    McKnight AJ, Woodman AM, Parkkonen M, Patterson CC, Savage DA, Forsblom C, Pettigrew KA, Sadlier D, Groop PH, Maxwell AP; Warren 3/UK GoKinD Study Group.

    Diabetologia. 2009 May;52(5):844-9. Epub 2009 Feb 27.PMID: 19247629 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.

    Araki S, Ng DP, Krolewski B, Wyrwicz L, Rogus JJ, Canani L, Makita Y, Haneda M, Warram JH, Krolewski AS.

    J Am Soc Nephrol. 2003 Aug;14(8):2015-24.PMID: 12874455 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.

    Keene KL, Mychaleckyj JC, Smith SG, Leak TS, Perlegas PS, Langefeld CD, Freedman BI, Rich SS, Bowden DW, Sale MM.

    Diabetes. 2008 Apr;57(4):1057-62. Epub 2008 Jan 9.PMID: 18184924 [PubMed - indexed for MEDLINE]Related articlesFree article